Briefly Bio
London
About Briefly Bio
Briefly Bio is a biotech platform that provides a solution to make lab work reproducible.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2024)
- Website: briefly.bio
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/briefly-bio-110042 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.